
Related
The S&P 500 dipped at the open on Tuesday as excitement over signs of a first successful late-stage COVID-19 vaccine trial faded, while investors continued to pull money out of the big tech companies that have benefited most from the pandemic.
The Dow Jones Industrial Average was up 18.51 points, or 0.06%, at the open to 29,254.17.
The S&P 500 opened lower by 17.61 points, or 0.50%, at 3,532.89, while the Nasdaq Composite dropped 142.81 points, or 1.22%, to 11,570.97 at the opening bell.
The Dow Jones Industrial Average was up 18.51 points, or 0.06%, at the open to 29,254.17.
The S&P 500 opened lower by 17.61 points, or 0.50%, at 3,532.89, while the Nasdaq Composite dropped 142.81 points, or 1.22%, to 11,570.97 at the opening bell.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Also Read
Israel begins coronavirus vaccine trials
Electronic Vaccine Intelligence Network to track COVID-19 vaccine
Oil gains as vaccine hopes outweigh lockdown impact
UK orders health service to be ready for vaccine by December
Yen pressured as vaccine hopes boost risk appetite
Asian stocks rally as investors applaud vaccine development